# Entyvio

NDC: 64764-300
Generic name: vedolizumab
Labeler / Manufacturer: Takeda Pharmaceuticals America, Inc.
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: Biologic License Application
Dosage form: INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
Routes: INTRAVENOUS
Marketing started: 20140520

FDA application: BLA125476

## Active ingredients

- VEDOLIZUMAB: 300 mg/5mL

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"64764-300"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=64764-300
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=6e94621c-1a95-4af9-98d1-52b9e6f1949c